EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 3.0

Reasons for Hospital Admissions in Chronic Hypercapnic COPD Patients on Long-Term Nocturnal Noninvasive Ventilation – A Prospective Observational Study

Simon Koschel, Sarah Bettina Stanzel, Doreen Kroppen, Marieke Duiverman iD, Maximilian Wollsching-Strobel, Daniel Majorski iD, Melanie Patricia Berger, Falk Schumacher, Johannes Fabian Holle, Wolfram Windisch iD, Maximilian Zimmermann iD

International Journal of Chronic Obstructive Pulmonary Disease · 2025

DOI: 10.2147/copd.s503742 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025. Verfasst von Simon Koschel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln gGmbH, Cologne, Germany. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Noninvasive Ventilation, Hypercapnia, Patient Admission. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Löwenstein medical SE, Philips,, RESMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-invasive ventilation (NIV) is vital for managing chronic hypercapnic respiratory failure in COPD patients, yet the impact of handling issues like mask compliance triggering hospitalisations is often underestimated.

Methods

A prospective, monocentric observational study was performed in COPD patients hospitalized for acute exacerbation with established home NIV therapy. Various questionnaires (CAT, SRI, BORG) and blood gas analysis were used to determine the severity and cause of respiratory insufficiency.

Results

59 patients (mean age 66.57 years ± 9.42, mean BMI 26.99 ± 8.63) were included. 54.24% were female (n=32). The overall cohort had a mean exacerbation rate of 2.24 ± 1.48 within the last 12 months prior to admission. Patients were divided into 4 sub cohorts based on their exacerbation trigger: infection (n=25), handling problem (n=12), non-infection (n=8), and an overlap cohort with evidence of both handling problem and non-handling problem (n=14). Significant differences exist when comparing exacerbation rate (handling-issue cohort: 2.58 ± 1.68 vs infection cohort: 1.76 ± 1.13, p=0.043), total hospital stay (handling-issue cohort: 9.25 ± 5.94 days vs infection cohort: 12.96 ± 5.76 days, p=0.039). There was no significant difference in health-related quality of life measured by the SRI (Summary Score 40.6±12.3 vs 46.8±14.2; p=0.103).

Discussion

In our study, we were able to show that handling problems are associated with frequent exacerbations, cause long hospitalisation periods and are associated with a reduced aspects of quality of life. Patient education and training should therefore play a key role in the treatment of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveNoninvasive VentilationHypercapniaPatient AdmissionLungRespiratory InsufficiencyHumansFemaleAgedProspective StudiesMaleMiddle AgedTime FactorsTreatment OutcomeDisease ProgressionQuality of LifeRisk FactorsLength of Stay

Stichwörter der Autor:innen

COPDNIVadherencehandling problemshospital admissionhypercapnic respiratory failure

Autor:innen und Institutionen

  • Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln gGmbH, Cologne, Germany.
  • Witten/Herdecke University, Witten, Germany.
  • Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Groningen Research Institute of Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.
  • Department of Rheumatology, Krankenhaus Porz Am Rhein, Cologne, Germany.
  • Cologne Merheim Hospital, Department of Neurology, Kliniken der Stadt Köln gGmbH, Cologne, Germany.

ORCID-Profile: Marieke Duiverman, Daniel Majorski, Wolfram Windisch, Maximilian Zimmermann

Förderung

  • Löwenstein medical SE
  • Philips,
  • RESMED
  • Vivisol
  • Fisher&Paykel

Zitieren

APA

Koschel, S., Stanzel, S. B., Kroppen, D., Duiverman, M., Wollsching-Strobel, M., Majorski, D., Berger, M. P., Schumacher, F., Holle, J. F., Windisch, W., & Zimmermann, M. (2025). Reasons for Hospital Admissions in Chronic Hypercapnic COPD Patients on Long-Term Nocturnal Noninvasive Ventilation – A Prospective Observational Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s503742

Vancouver

Koschel S, Stanzel SB, Kroppen D, Duiverman M, Wollsching-Strobel M, Majorski D, et al. Reasons for Hospital Admissions in Chronic Hypercapnic COPD Patients on Long-Term Nocturnal Noninvasive Ventilation – A Prospective Observational Study. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s503742

BibTeX
@article{Koschel2025,
  author = {Koschel, Simon and Stanzel, Sarah Bettina and Kroppen, Doreen and Duiverman, Marieke and Wollsching-Strobel, Maximilian and Majorski, Daniel and Berger, Melanie Patricia and Schumacher, Falk and Holle, Johannes Fabian and Windisch, Wolfram and Zimmermann, Maximilian},
  title = {Reasons for Hospital Admissions in Chronic Hypercapnic COPD Patients on Long-Term Nocturnal Noninvasive Ventilation – A Prospective Observational Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  doi = {10.2147/copd.s503742}
}
Kostenlos starten →